Submission Details
| 510(k) Number | K950169 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 17, 1995 |
| Decision Date | May 23, 1996 |
| Days to Decision | 492 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K950169 is an FDA 510(k) clearance for the RIBOSOMAL P EIA TEST SYSTEM, a Anti-ribosomal P Antibodies (Class II — Special Controls, product code MQA), submitted by Hogan & Hartson (Washington, US). The FDA issued a Cleared decision on May 23, 1996, 492 days after receiving the submission on January 17, 1995. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5100.
| 510(k) Number | K950169 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 17, 1995 |
| Decision Date | May 23, 1996 |
| Days to Decision | 492 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | MQA — Anti-ribosomal P Antibodies |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5100 |